Pemetrexed FDA Link

A guanine-derived ANTINEOPLASTIC AGENT that functions as a NUCLEIC ACID SYNTHESIS INHIBITOR through its binding to, and inhibition of, THYMIDYLATE SYNTHASE.

Also Known As:

MTA; LY231514; Alimta; LY 231,514; LY 231514; LY-231,514; LY-231514; N- (4- (2- (2- amino- 3,4- dihydro- 4- oxo- 7H- pyrrolo(2,3- d)pyrimdin- 5- yl)ethyl)benzoyl)glutamic acid; Pemetrexed Disodium; 231,514, LY; 231514, LY; Disodium, Pemetrexed; L-Glutamic acid, N- (4- (2- (2- amino- 4,7- dihydro- 4- oxo- 1H- pyrrolo(2,3- d)pyrimidin- 5- yl)ethyl)benzoyl)-

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Purines: 651
      - Purinones: 2
        Hypoxanthines: 1
        Guanine: 1793
        Pemetrexed: 3680
Amino Acids, Peptides, and Proteins: 1
- Amino Acids: 30675
  - Acidic Amino Acids: 44
    - Glutamates: 45
      - Pemetrexed: 3680
  - Dicarboxylic Amino Acids: 20
    - Glutamates: 45
      - Pemetrexed: 3680

Takashi Kagoshima Selected Research

Takashi Kagoshima Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure